Assyro AI

FDA Orange Book · active-ingredient family

Polyethylene glycol 3350

Polyethylene glycol 3350 is approved as 1 brand and 18 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:MIRALAX · NDA 022015

1

Brand (NDA)

18

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · for solution

ProductApplicantApplicationTEApproved
MIRALAXRLD×2BAYER HEALTHCARE LLCNDA 022015Oct 06, 2006

Generic (ANDA) products (18)

ProductApplicantApplicationTEApproved
POLYETHYLENE GLYCOL 3350×2ANNORA PHARMAANDA 214990Apr 14, 2021
POLYETHYLENE GLYCOL 3350×2AUROBINDO PHARMA LTDANDA 209017Apr 09, 2018
POLYETHYLENE GLYCOL 3350NUVO PHARMS INCANDA 206105Oct 28, 2016
POLYETHYLENE GLYCOL 3350×2STRIDES PHARMAANDA 203928Aug 24, 2016
POLYETHYLENE GLYCOL 3350×2ANI PHARMSANDA 202850Dec 15, 2015
POLYETHYLENE GLYCOL 3350STRIDES PHARMA INTLANDA 079214Jan 31, 2013
POLYETHYLENE GLYCOL 3350SHREE HARI INTLANDA 202071Dec 28, 2012
POLYETHYLENE GLYCOL 3350PADDOCK LLCANDA 090567Oct 15, 2009
POLYETHYLENE GLYCOL 3350ALLIEDANDA 090812Oct 07, 2009
GLYCOLAX×2LANNETT CO INCANDA 090600Oct 06, 2009
POLYETHYLENE GLYCOL 3350×2MYLANANDA 078915Oct 06, 2009
POLYETHYLENE GLYCOL 3350×2NOVEL LABS INCANDA 091077Oct 06, 2009
POLYETHYLENE GLYCOL 3350×2PPI-DACANDA 090685Oct 06, 2009
POLYETHYLENE GLYCOL 3350NEXGEN PHARMA INCANDA 077706Sep 27, 2006
POLYETHYLENE GLYCOL 3350BRECKENRIDGE PHARMANDA 077736May 26, 2006
POLYETHYLENE GLYCOL 3350PADDOCK LLCANDA 077893May 26, 2006
POLYETHYLENE GLYCOL 3350TEVA PHARMSANDA 077445May 04, 2006
GLYCOLAXLANNETT CO INCANDA 076652Jul 02, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Polyethylene glycol 3350 — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.